Author

J. Dziekan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:plant (other)· 1 Assay:proteomics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Z. Bozdech· 2 shared A. El Sahili· 1 shared A. Kam· 1 shared A. Partridge· 1 shared A. R. Fernie· 1 shared B. Usadel· 1 shared D. Mutwil-Anderwald· 1 shared D. Olsen· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPlant Biology

Z. Bozdech

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genomic, transcriptomic, and metabolomic analysis of Traditional Chinese Medicine plant Oldenlandia corymbosa reveals the biosynthesis and mode of action of anti-cancer metabolites

I. Julca, D. Mutwil-Anderwald, V. Manoj, Z. Khan, S. K. Lai, L. K. Yang, I. T. Beh, J. Dziekan, Y. P. Lim, S. K. Lim, Y. W. Low, Y. I. Lam, Y. Mu, Q. W. Tan, P. Nuc, , M. Mutwil

This study identifies ursolic acid as the main anti-cancer compound in Oldenlandia corymbosa and reveals its mode of action through genomic, transcriptomic, and metabolomic analysis.

bioRxiv · Jun 14, 2022 · PreprintPlant Biology

Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development

G. Wirjanata, J. Lin, J. Dziekan, A. El Sahili, Z. Chung, S. Tjia, N. E. B. Zulkifli, J. Boentoro, R. Tham, S. J. Lai, K. Go, Y. Han, A. Partridge, D. Olsen, N. Prabhu, , Z. Bozdech

This study identifies falcilysin as a target of anti-malaria drugs and reveals a shared inhibitory pocket that could guide new drug development.

bioRxiv · Apr 8, 2021Microbiology